These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35833294)

  • 1. Madurella mycetomatis grains within a eumycetoma lesion are clonal.
    Nyuykonge B; Siddig EE; Konings M; Bakhiet S; Verbon A; Klaassen CHW; Fahal AH; van de Sande WWJ
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35833294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Short-Tandem-Repeat Assay (
    Nyuykonge B; Eadie K; Zandijk WHA; Ahmed SA; Desnos-Ollivier M; Fahal AH; de Hoog S; Verbon A; van de Sande WWJ; Klaassen CHW
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298608
    [No Abstract]   [Full Text] [Related]  

  • 3. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
    Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
    Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
    Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan.
    Litvintseva AP; Bakhiet S; Gade L; Wagner DD; Bagal UR; Batra D; Norris E; Rishishwar L; Beer KD; Siddig EE; Mhmoud NA; Chow NA; Fahal A
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010787. PubMed ID: 36322569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
    Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
    Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature.
    Zaid DM; Bakheet OE; Ahmed ES; Abdalati F; Mhmoud NA; Mohamed ESW; Bakhiet SM; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):411-414. PubMed ID: 33406268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eumycetoma caused by Madurella mycetomatis in a mare.
    Elad D; Blum S; Kol A; Ederi N; David D
    Med Mycol; 2010 Jun; 48(4):639-42. PubMed ID: 19886776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.
    Verwer PE; Notenboom CC; Eadie K; Fahal AH; Verbrugh HA; van de Sande WW
    PLoS Negl Trop Dis; 2015; 9(9):e0004061. PubMed ID: 26332238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.
    Ahmed AO; van Leeuwen W; Fahal A; van de Sande W; Verbrugh H; van Belkum A
    Lancet Infect Dis; 2004 Sep; 4(9):566-74. PubMed ID: 15336224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.
    Geneugelijk K; Kloezen W; Fahal AH; van de Sande WW
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2754. PubMed ID: 24675764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Madurella mycetomatis mycetoma secondary to knee eumycetoma, Senegal.
    Diongue K; Diallo MA; Sarr L; Seck MC; Bréchard L; Ndiaye M; Badiane AS; Ranque S; Ndiaye D
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009238. PubMed ID: 33764976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.
    Ahmed A; van de Sande W; Verbrugh H; Fahal A; van Belkum A
    J Clin Microbiol; 2003 Oct; 41(10):4537-41. PubMed ID: 14532179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metagenomic detection of eumycetoma causative agents   from households of patients residing in two Sudanese endemic villages in White Nile State.
    Santona A; Mhmoud NA; Siddig EE; Deligios M; Fiamma M; Paglietti B; Bakhiet SM; Rubino S; Fahal AH
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010385. PubMed ID: 36040926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against
    Ma J; Eadie K; Schippers M; Fahal A; Laleu B; Verbon A; van de Sande WWJ
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
    Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and identification of Madurella mycetomatis from two cases of black grain mycetoma in Libya.
    Ellabib MS; Refaai A; Khalifa Z; Kavanagh K
    Mycoses; 2003 Sep; 46(8):339-41. PubMed ID: 12950906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression.
    van de Sande WW; Janse DJ; Hira V; Goedhart H; van der Zee R; Ahmed AO; Ott A; Verbrugh H; van Belkum A
    J Immunol; 2006 Aug; 177(3):1997-2005. PubMed ID: 16849514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.